Trial the Evoke System
- One of the advantages of SCS therapy is that you can try it before deciding on a permanent implant.
- The goal of the trial is to reduce your pain by at least 50% and improve your ability to do the things you find challenging due to your pain.
- In the Clinical Study for FDA approval of the Evoke System, 83% of patients experienced a 50% or greater reduction in pain and 59% of patients experienced a 80% or greater reduction in pain, as well as improvements in quality of life, functional status, mood and sleep.1
- External Trial Stimulator
- 12-Contact Percutaneous Leads
- Remote Control to adjust therapy
Products used during a trial include: